AbbVie and Eisai Announce an approval for additional indication of HUMIRA
AbbVie and Eisai Announce an approval for additional indication of HUMIRA TOKYO, Nov 27, 2020 – (JCN Newswire) – AbbVie
Read moreAbbVie and Eisai Announce an approval for additional indication of HUMIRA TOKYO, Nov 27, 2020 – (JCN Newswire) – AbbVie
Read moreCanada NewsWire VANCOUVER, BC, Nov. 25, 2020 VANCOUVER, BC, Nov. 25, 2020/CNW/ – Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company
Read moreNovo Integrated Sciences, Inc. Engages Investor Acquisition Advisors Bellevue, Washington–(Newsfile Corp. – November 18, 2020) – Novo Integrated Sciences, Inc.
Read moreCanada NewsWire SAN FRANCISCO and NORTH CHICAGO, Ill., Nov. 25, 2020 SAN FRANCISCO and NORTH CHICAGO, Ill., Nov. 25, 2020/CNW/
Read more